Former Sen. Kyrsten Sinema on ibogaine and psychedelicsnews2025-05-30T13:09:38+00:00May 30th, 2025|Endpoints News|
#ASCO25: Pfizer’s Braftovi combo doubles survival time for some colorectal cancer patientsnews2025-05-30T12:00:22+00:00May 30th, 2025|Endpoints News|
Sanofi, Regeneron report underwhelming data for IL-33 antibody itepekimab, shares dropnews2025-05-30T11:07:29+00:00May 30th, 2025|Endpoints News|
Summit says bispecific misses overall survival in closely-watched lung cancer studynews2025-05-30T10:31:31+00:00May 30th, 2025|Endpoints News|
Intellia reports case of liver toxicity in ATTR gene editing studynews2025-05-29T14:35:48+00:00May 29th, 2025|Endpoints News|
Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival missnews2025-05-29T12:14:21+00:00May 29th, 2025|Endpoints News|
Oric locks down cash for Phase 3 prostate cancer trial with early data in handnews2025-05-29T11:14:03+00:00May 29th, 2025|Endpoints News|
PepGen ditches Duchenne programs after mid-stage failnews2025-05-29T10:58:01+00:00May 29th, 2025|Endpoints News|
Will the FDA approve Moderna’s next-gen Covid shot?news2025-05-28T18:35:57+00:00May 28th, 2025|Endpoints News|
GSK, Spero report Phase 3 win for UTI antibiotic; Spero’s stock soarsnews2025-05-28T14:47:02+00:00May 28th, 2025|Endpoints News|
